Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anil Shanker

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Translational Medicine|June 14, 2013
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patientsMaria Libera Ascierto, Michael O Idowu, Yingdong Zhao, et al.
Clinical Lung Cancer|August 19, 2020
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)Jyoti D Patel, Ju-Whei Lee, David P Carbone, et al.
Frontiers in Immunology|October 8, 2025
CD8<sup>+</sup> T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumorsRoman V Uzhachenko, Salvador González Ochoa, Thanigaivelan Kanagasabai, et al.
JMIR AI|June 14, 2024
Developing Ethics and Equity Principles, Terms, and Engagement Tools to Advance Health Equity and Researcher Diversity in AI and Machine Learning: Modified Delphi ApproachRachele Hendricks-Sturrup, Malaika Simmons, Shilo Anders, et al.
Cancer Research|April 10, 2021
Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET ProteinsPoonam Tewary, Alan D Brooks, Ya-Ming Xu, et al.
Journal for Immunotherapy of Cancer|May 9, 2019
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal for Immunotherapy of Cancer|April 4, 2019
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Plos One|May 29, 2024
Correction: Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel diseaseTanu Rana, Olga Y Korolkova, Girish Rachakonda, et al.
Plos One|March 10, 2021
Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel diseaseTanu Rana, Olga Y Korolkova, Girish Rachakonda, et al.
Journal of the National Cancer Institute|May 17, 2023
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppressionJason V Evans, Shankar Suman, Mounika Uttam L Goruganthu, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Translational Medicine|June 14, 2013
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patientsMaria Libera Ascierto, Michael O Idowu, Yingdong Zhao, et al.
Clinical Lung Cancer|August 19, 2020
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)Jyoti D Patel, Ju-Whei Lee, David P Carbone, et al.
Frontiers in Immunology|October 8, 2025
CD8<sup>+</sup> T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumorsRoman V Uzhachenko, Salvador González Ochoa, Thanigaivelan Kanagasabai, et al.
JMIR AI|June 14, 2024
Developing Ethics and Equity Principles, Terms, and Engagement Tools to Advance Health Equity and Researcher Diversity in AI and Machine Learning: Modified Delphi ApproachRachele Hendricks-Sturrup, Malaika Simmons, Shilo Anders, et al.
Cancer Research|April 10, 2021
Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET ProteinsPoonam Tewary, Alan D Brooks, Ya-Ming Xu, et al.
Journal for Immunotherapy of Cancer|May 9, 2019
Correction to: Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T-cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Journal for Immunotherapy of Cancer|April 4, 2019
Determinant roles of dendritic cell-expressed Notch Delta-like and Jagged ligands on anti-tumor T cell immunityElena E Tchekneva, Mounika U L Goruganthu, Roman V Uzhachenko, et al.
Plos One|May 29, 2024
Correction: Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel diseaseTanu Rana, Olga Y Korolkova, Girish Rachakonda, et al.
Plos One|March 10, 2021
Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel diseaseTanu Rana, Olga Y Korolkova, Girish Rachakonda, et al.
Journal of the National Cancer Institute|May 17, 2023
Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppressionJason V Evans, Shankar Suman, Mounika Uttam L Goruganthu, et al.
Pageof 7